Sarmiento, Mary Jane B.
HRN: 22-78-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
CEFUROXIME 1.5GM (VIAL)
05/07/2023
05/08/2023
IVT
1.5 Gms
On Call To OR
Rpt LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes